Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA)

46 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2024.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2.15M shares of 54.8M outstanding shares and own 3.93% of the company stock.
Largest 10 shareholders include FARALLON CAPITAL MANAGEMENT LLC (1.56M shares), Voya Investment Management LLC (202K shares), Bank of New York Mellon Corp (143K shares), MORGAN STANLEY (106K shares), Penserra Capital Management LLC (65.5K shares), JPMORGAN CHASE & CO (34K shares), BARCLAYS PLC (32.4K shares), NEW YORK STATE COMMON RETIREMENT FUND (16.4K shares), Legal & General Group Plc (4.34K shares), and LRI Investments, LLC (2K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.